Cho, J. S., Her, S., Baek, J. Y., Park, M., Kim, H. D., Jeong, M. H., . . . Park, S. J. (2010). Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Glycoprotein IIb/IIIa Inhibitor. The Korean Academy of Medical Sciences.
Chicago Style CitationCho, Jung Sun, et al. Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention With Glycoprotein IIb/IIIa Inhibitor. The Korean Academy of Medical Sciences, 2010.
Cita MLACho, Jung Sun, et al. Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention With Glycoprotein IIb/IIIa Inhibitor. The Korean Academy of Medical Sciences, 2010.